Korea Gut Health Supplements Market Size & Outlook, 2025-2033

Korea Gut Health Supplements Market Insights

Deep Market Insights analysis indicates that the Korea Gut Health Supplements Market size, valued at USD 154.75 Million in 2024, is expected to expand to USD 340.89 Million by 2033.
The Korea market is forecasted to expand at a CAGR of 9.29% spanning 2026–2033.
Probiotic Strains held the leading position among Ingredient Type segments in 2024, based on market size.
Prebiotic Fibers is projected to post the fastest growth rate, sustaining its position as the most attractive Ingredient Type segment during the forecast horizon.

In 2024, Korea represented 0.99% of the overall global Gut Health Supplements Market size.
United States is projected to lead the global Gut Health Supplements Market size by 2033.
Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2033.
Australia is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 358.17 Million by 2033.

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 154.75 Million
Market Size In 2033	USD 340.89 Million
Largest segment	Probiotic Strains
Units	Revenue in USD Million
CAGR	9.29% (2025-2033)
Segmnetation Covered
Ingredient Type	Probiotic Strains Prebiotic Fibers Postbiotic Compounds Digestive Enzymes
Health Benefit	Digestive Balance Immune System Support Inflammation Reduction Metabolic Health Improvement
Dosage Form	Capsules And Tablets Powdered Supplements Liquid Formulations Functional Gummies
Distribution Channel	Pharmacies Online Platforms Health Food Stores Direct To Consumer Sales
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Ingredient Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Probiotic Strains	XX.x	XX.x	XX.x	61.92	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Prebiotic Fibers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Postbiotic Compounds	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Digestive Enzymes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Health Benefit	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Digestive Balance	XX.x	XX.x	XX.x	68.06	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Immune System Support	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Inflammation Reduction	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Metabolic Health Improvement	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Dosage Form	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Capsules And Tablets	XX.x	XX.x	XX.x	66.31	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Powdered Supplements	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Liquid Formulations	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Functional Gummies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Distribution Channel	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Pharmacies	XX.x	XX.x	XX.x	68.18	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Online Platforms	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Health Food Stores	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Direct To Consumer Sales	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x